CGNSF (Cognetivity Neurosciences) Cash And Cash Equivalents : $0.01 Mil (As of Oct. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences Cash And Cash Equivalents?

Cognetivity Neurosciences's quarterly cash and cash equivalents declined from Apr. 2023 ($0.53 Mil) to Jul. 2023 ($0.02 Mil) but then stayed the same from Jul. 2023 ($0.02 Mil) to Oct. 2023 ($0.01 Mil).

Cognetivity Neurosciences's annual cash and cash equivalents increased from Jan. 2021 ($1.07 Mil) to Jan. 2022 ($1.09 Mil) and increased from Jan. 2022 ($1.09 Mil) to Jan. 2023 ($1.67 Mil).

Cognetivity Neurosciences Cash And Cash Equivalents Historical Data

The historical data trend for Cognetivity Neurosciences's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cognetivity Neurosciences Cash And Cash Equivalents Chart

Cognetivity Neurosciences Annual Data

Trend

Jan17

Jan18

Jan19

Jan20

Jan21

Jan22

Jan23

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.19

0.44

1.07

1.09

1.67

Cognetivity Neurosciences Quarterly Data
	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23
Cash And Cash Equivalents	Get a 7-Day Free Trial															3.01	1.67	0.53	0.02	0.01

Cognetivity Neurosciences Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Cognetivity Neurosciences (OTCPK:CGNSF) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Cognetivity Neurosciences Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (OTCPK:CGNSF) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

1UB:Germany CGN:Canada

Address

800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6

Website

https://www.cognetivity.com

Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.

Cognetivity Neurosciences Headlines

From GuruFocus

Three Companies Using AI and Innovation to Lead Healthcare Sector

By ACCESSWIRE AccessWire • 04-12-2019

The Most Innovative Healthcare AI Developments of 2019

By ACCESSWIRE AccessWire • 04-12-2019